AQP4 and disease recurrence: When comparing MOG and AQP4-associated NMO spectrum disorders, it has been found that NMO patients with MOG antibodies tended to have a single attack and/or fewer attacks than NMO patients with AQP4 antibodies who experienced significantly higher rates of relapsing disease [23].